These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females. Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920 [TBL] [Abstract][Full Text] [Related]
3. Effect of felodipine on the serum lipid profile of patients with hypertension. Kaur M; Kaur K; Bedi GK; Sidhu GS; Sikand R Indian J Clin Biochem; 2000 Jul; 15(2):63-7. PubMed ID: 23105243 [TBL] [Abstract][Full Text] [Related]
4. Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS. Toal CB; Meredith PA; Elliott HL Blood Press; 2012 Jul; 21 Suppl 1(Suppl 1):3-10. PubMed ID: 22762301 [TBL] [Abstract][Full Text] [Related]
5. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Aritomi S; Koganei H; Wagatsuma H; Mitsui A; Ogawa T; Nitta K; Konda T Heart Vessels; 2010 Nov; 25(6):549-55. PubMed ID: 20922532 [TBL] [Abstract][Full Text] [Related]
6. [Differentiation and evaluation of calcium antagonists in therapy of arterial hypertension]. Holzgreve H Internist (Berl); 2003 Apr; 44(4):483-90. PubMed ID: 12914406 [No Abstract] [Full Text] [Related]
7. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension. Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880 [TBL] [Abstract][Full Text] [Related]
8. Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls. Leppert J; Nilsson H; Myrdal U; Edvinsson L; Hedner T; Ringqvist I Cardiovasc Drugs Ther; 1993 Dec; 7(6):901-7. PubMed ID: 8011569 [TBL] [Abstract][Full Text] [Related]
9. Antianginal effects of amlodipine at a single dose on exertional angina patients using treadmill exercise testing--a randomized crossover study in comparison with placebo. Kishida H; Hata N; Kunimi T; Miyagawa H; Nishiyama H; Katoh K Cardiovasc Drugs Ther; 1992 Oct; 6(5):481-7. PubMed ID: 1450093 [TBL] [Abstract][Full Text] [Related]
10. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial. Leonetti G; Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895 [TBL] [Abstract][Full Text] [Related]
12. The role of calcium channel blockers in the treatment of hypertension. Halperin AK; Cubeddu LX Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651 [No Abstract] [Full Text] [Related]
13. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus. Lopez LM; Thorman AD; Mehta JL Am J Cardiol; 1990 Nov; 66(17):1269-71. PubMed ID: 2146871 [No Abstract] [Full Text] [Related]
14. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T Cardiology; 1992; 80 Suppl 1():37-45. PubMed ID: 1534714 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424 [TBL] [Abstract][Full Text] [Related]